IRIS
RICCI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.316
EU - Europa 1.674
AS - Asia 1.651
AF - Africa 202
SA - Sud America 175
OC - Oceania 115
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.138
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.239
SG - Singapore 602
CN - Cina 300
DE - Germania 277
UA - Ucraina 214
IT - Italia 213
IE - Irlanda 210
GB - Regno Unito 191
IN - India 173
RU - Federazione Russa 169
HK - Hong Kong 159
BR - Brasile 126
AU - Australia 113
FR - Francia 103
ID - Indonesia 101
SE - Svezia 77
KR - Corea 61
PL - Polonia 55
FI - Finlandia 48
MX - Messico 47
NG - Nigeria 35
TR - Turchia 34
GH - Ghana 33
KE - Kenya 33
PK - Pakistan 31
TW - Taiwan 28
NL - Olanda 27
PH - Filippine 27
EG - Egitto 26
ET - Etiopia 26
CA - Canada 22
ZA - Sudafrica 20
MY - Malesia 19
BE - Belgio 18
SA - Arabia Saudita 15
IR - Iran 14
EC - Ecuador 12
JP - Giappone 11
KG - Kirghizistan 11
NP - Nepal 11
AT - Austria 10
VN - Vietnam 10
ES - Italia 9
NO - Norvegia 9
RO - Romania 9
MG - Madagascar 8
PE - Perù 8
BD - Bangladesh 7
CL - Cile 7
CO - Colombia 7
PT - Portogallo 7
UG - Uganda 7
AR - Argentina 6
EE - Estonia 6
IQ - Iraq 6
KH - Cambogia 6
VE - Venezuela 5
CH - Svizzera 4
CM - Camerun 4
EU - Europa 4
JO - Giordania 4
NI - Nicaragua 4
CZ - Repubblica Ceca 3
GR - Grecia 3
IL - Israele 3
KW - Kuwait 3
KZ - Kazakistan 3
MA - Marocco 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TZ - Tanzania 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
ML - Mali 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 21.138
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.669
Wilmington 4.382
Houston 4.359
Fairfield 505
Singapore 424
Ann Arbor 393
Chandler 377
Ashburn 285
Seattle 241
Cambridge 197
Dublin 195
Jacksonville 184
Medford 160
Dearborn 140
Hong Kong 130
New York 95
Beijing 85
Rome 81
Santa Clara 77
Lawrence 73
Boardman 71
Zhengzhou 52
Kraków 49
Moscow 41
San Diego 31
Nairobi 29
Melbourne 28
Milan 28
Mülheim 26
Perth 25
Shanghai 24
Council Bluffs 23
Accra 21
Los Angeles 21
Malang 21
Menlo Park 21
The Dalles 20
Waurn Ponds 20
Jakarta 19
Chennai 18
Guangzhou 18
London 18
Brussels 17
Bodorgan 15
Riyadh 15
Lagos 14
San Francisco 14
Bengaluru 13
Kuala Lumpur 13
Nanjing 13
Aksum 12
Munich 12
Nuremberg 12
Redwood City 12
Manchester 11
Mexico City 11
Palo Alto 11
Taipei 11
Cairo 10
Istanbul 10
Kathmandu 10
Phoenix 10
Armidale 9
Chicago 9
Coimbatore 9
Denpasar 9
Hefei 9
Kochi 9
Lahore 9
Medan 9
Mountain View 9
Norwalk 9
Seoul 9
Sydney 9
Alexandria 8
Antananarivo 8
Birmingham 8
Cardiff 8
Creede 8
Kolkata 8
Pune 8
San Jose 8
São Paulo 8
University Park 8
Delhi 7
Durban 7
Feltre 7
Karachi 7
Kunming 7
Las Vegas 7
Quezon City 7
Torreón 7
Vadodara 7
Washington 7
Abuja 6
Belo Horizonte 6
Frankfurt am Main 6
Helsinki 6
Hyderabad 6
Lisbon 6
Totale 18.216
Salva come PNG Salva come JPEG
Nome #
A literature review of hypertensive retinopathy: systemic correlations and new technologies 1.431
Validity and limitations of the Nidek NT-4000 non-contact tonometer: a clinical study 472
Visual disability and quality of life in glaucoma patients 458
Review of nutrient actions on age-related macular degeneration 457
Electro-oculography in pigment dispersion syndrome 448
Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry. 440
Age-related macular degeneration: insights into inflammatory genes 438
Clusterin in stool: a new biomarker for colon cancer screening? 429
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 424
Automatic Segmentation of Posterior Pole Retinal Layers In Patients with Early Stage Glaucoma Using Spectral Domain Optical Coherence Tomography 424
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 421
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks 419
Age-specific changes in the prevalence and management of optically correctable visual impairment between 1988 and 2000: the Ponza Eye Study 418
Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization 417
Prevalence of blindness and low vision in an Italian population: A comparison with other European studies 415
The 12-year Incidence of Glaucoma and Glaucoma-related Visual Field Loss in Italy: The Ponza Eye Study 413
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 412
Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinpathy (AZOOR) with adalimumab (Humira™). 396
Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy 395
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab 394
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy 393
Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration 391
Incidence of visual loss in the Ponza Eye Study, Italy 389
Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy 383
CLU "in and out": looking for a link. 382
Age-specific changes in the prevalence of best-corrected visual impairment in an italian population 382
Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry 382
Prevalence and risk factors of vision impairment among children of employees of Telecom, Italy. 382
Low contrast visual acuity in pseudophakic patients implanted with an anterior surface modified prolate intraocular lens 378
Clusterin in stool: a new biomarker for colon cancer screening? 370
Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999 Jun;6(2):95-103. 370
ICGA Guided Low-fluence Photodynamic Therapy Combined With PRN Ranibizumab For Active Polypoidal Choroidal Vasculopathy 367
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 367
Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis 363
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 363
CLU "in and out": looking for a link 362
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 361
Evaluation of fixation stability using different targets with the MP1 microperimeter 357
Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration 339
Monolateral Corectopia: considerations about associated myopia. A case report. 337
Indocyanine green angiography and optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration 305
L’epidemiologia del glaucoma 304
Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population 300
Moorfields Regression Analysis (MRA) and Glaucoma Probability Score (GPS) Agreement in Daily Clinical Practice 290
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization 290
Towards the application of precision medicine in age-related macular degeneration 280
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: The RETAIN study 244
The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A. 238
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 222
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial 204
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 201
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 184
Ultrasound-Guided Vacuum-Assisted Biopsy in Small Breast: A Cost-Saving Solution 180
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa 174
Platelet-rich plasma as treatment for persistent ocular epithelial defects 129
Thickness mapping of individual retinal layers and sectors by Spectralis Spectral Domain-optical Coherence Tomography in Autosomal Dominant Optic Atrophy 57
Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: An expert opinion 57
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials 54
A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up 52
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data 49
Antimicrobial activity on contact lenses contaminated with planktonic and sessile forms of bacteria: An experimental approach 47
Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders 47
Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy 47
Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets 46
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 45
Aflibercept in persistent neovascular AMD: Comparison of different treatment strategies in switching therapy 42
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases 34
Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study 34
An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification 33
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration 28
Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach 28
Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches 28
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 26
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE study 24
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 21
Paper card-like electrochemical platform as a smart point-of-care device for reagent-free glucose measurement in tears 19
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial 18
Longitudinal Structural and Functional Evaluation of Dark-without-Pressure Fundus Lesions in Patients with Autoimmune Diseases 18
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization 14
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 13
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study 13
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries (Eye, (2023), 37, 16, (3351-3359), 10.1038/s41433-023-02540-w) 8
Totale 21.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.093 0 0 0 0 0 0 0 0 0 423 324 346
2020/20213.003 328 356 312 353 287 329 341 332 92 115 125 33
2021/2022703 14 42 46 26 12 55 120 30 36 53 83 186
2022/2023966 106 81 24 100 104 213 76 93 84 2 60 23
2023/20241.067 91 45 70 71 99 172 88 60 70 72 49 180
2024/20252.136 132 430 271 146 157 194 253 205 276 72 0 0
Totale 21.386